AXE archer materials limited

Break it Down: Archer innovativing at-home kidney checkTwo...

  1. 1,768 Posts.
    lightbulb Created with Sketch. 334

    Break it Down: Archer innovativing at-home kidney check

    Two medical companies have formed a strategic partnership to create an at-home kidney disease diagnostic test.

    Archer Materials (ASX:AXE) is partnering with Hylid Diagnostics to develop an at home kidney disease testing kit for patients.

    Leveraging Hylid’s expertise in blood hemolysis sensors and Archer's potassium sensing technology, the dynamic duo hopes to make a real impact for patients struggling with chronic kidney disease.

    Watch the video to find out more.

    Originally published as Break it Down: Archer innovativing at-home kidney check




 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
28.0¢
Change
-0.015(5.08%)
Mkt cap ! $71.35M
Open High Low Value Volume
29.0¢ 29.0¢ 27.5¢ $55.36K 197.6K

Buyers (Bids)

No. Vol. Price($)
2 30326 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 15979 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
AXE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.